Financial Health Report: Caredx Inc (CDNA)’s Ratios Tell a Tale

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

Caredx Inc (NASDAQ: CDNA) closed the day trading at $18.09 down -4.39% from the previous closing price of $18.92. In other words, the price has decreased by -$4.39 from its previous closing price. On the day, 0.85 million shares were traded.

Ratios:

For a better understanding of CDNA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.77. For the most recent quarter (mrq), Quick Ratio is recorded 3.72 and its Current Ratio is at 3.94. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.

On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.

BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 10 ’25 when GEORGE W BICKERSTAFF bought 20,000 shares for $18.36 per share.

Novack Jeffrey Adam sold 3,512 shares of CDNA for $81,829 on Feb 04 ’25. The Secretary and General Counsel now owns 104,677 shares after completing the transaction at $23.30 per share. On Feb 04 ’25, another insider, Jeffrey Adam Novack, who serves as the Officer of the company, bought 3,512 shares for $23.32 each.

Valuation Measures:

As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.00 while its Price-to-Book (P/B) ratio in mrq is 2.62.

Stock Price History:

Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $7.42. The 50-Day Moving Average of the stock is -19.14%, while the 200-Day Moving Average is calculated to be -20.56%.

Shares Statistics:

A total of 54.77M shares are outstanding, with a floating share count of 51.92M. Insiders hold about 6.32% of the company’s shares, while institutions hold 101.11% stake in the company.

Most Popular